NewAmsterdam Pharma Co. NV (NAMS)
35.58
+0.95
(+2.74%)
USD |
NASDAQ |
Feb 20, 16:00
35.51
-0.07
(-0.20%)
After-Hours: 20:00
NewAmsterdam Pharma Profit Margin (Quarterly) : -234.1K% for Dec. 31, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| uniQure NV | -2.18K% |
| ProQR Therapeutics NV | -381.9% |
| argenx SE | -- |
| Pharming Group NV | 7.71% |
| Pharvaris NV | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -27.36% |
| Return on Assets | -25.14% |
| Return on Invested Capital | -27.35% |
| Gross Profit Margin (Quarterly) | -84.38% |
| Operating Margin (Quarterly) | -206.2K% |
| Return on Net Operating Assets | -1.88K% |